Now Made in New York City: Much-Needed Coronavirus Test Kits

Harris Goldstein, M.D., and Brian Pelowski discuss Einstein's success in transforming a lab to provide viral transport medium after the New York City Economic Development Corporation requested the college's assistance for its initiative to produce 50,000 COVID-19 testing kits each week. Dr. Goldstein is associate dean for scientific resources and Mr. Pelowski is assistant dean for scientific operations.

Additional coverage of the initiative includes CBS NewYork, US News & World Report, NBC 4 New York, ABC7NewYork, PIX11, AMNewYork, The Staten Island Advance, Patch, Gothamist, WCBS880, The Daily News, and The New York Post.


Can an Immune Strategy Used to Treat Cancer Also Wipe Out HIV Infections?

Harris Goldstein, M.D., describes his new research, in Science Translational Medicine, that uses genetically reprogrammed T cells to successfully fight HIV infection in mice. Dr. Goldstein is professor of pediatrics and of microbiology & immunology and director of the Einstein-Rockefeller-CUNY Center for AIDS Research.


Trump's HIV Plan Met With Both Cautious Optimism, Flat-Out Skepticism

Harris Goldstein, M.D., says he is encouraged by the prospect of increased federal funds for regional AIDS research centers that help advance treatments and improve health outcomes. Dr. Goldstein is director of the Einstein-Rockefeller-CUNY Center for AIDS Research and an attending physician at Children’s Hospital at Montefiore.


Why Is the HIV Vaccine Taking So Long?

Harris Goldstein, M.D., discusses the difficulty of developing a vaccine for HIV. Dr. Goldstein is professor of pediatrics and of microbiology & immunology at Einstein and director of the Einstein-Rockefeller-CUNY Center for AIDS Research.


Science Daily and BBC report on a technique developed by Einstein researchers that could influence the way type 1 diabetes is treated in the future, using transplanted insulin-producing pancreatic cells.

More coverage on this story

BBC